The Biotech Project Podcast Dives into the Passionate Vision of Jeff Galvin
The Biotech Project podcast hosts Scott J Resnik, MBA, NYS EMT-CC, and John Walsh, MD, sit down with American Gene Technologies® founder ...
Developing Therapeutics That Teach the Body to Heal Itself
Future Watch: Gene & Cell Therapy
A Revolution In Medicine And Healthcare Blog
Future Watch: Gene & Cell Therapy
A Revolution In Medicine And Healthcare Blog
- All
- Biotech Investment
- Cell Therapy
- Cell Therapy Investing
- Disease
- Gene Therapy
- Gene Therapy Investing
- HIV
- HIV Cure
- HIV History
- HIV/AIDS Research
- Innovation & Business
- People Changing Lives
- Rare Disease Research
- Scientific Breakthroughs
American Gene Technologies Celebrates Another Year of Progress
In 2022, the world was collectively compelled to endure a surge in viral outbreaks, the horror of the Russia-Ukraine war and rampant ...
Phase 1 HIV Clinical Trial Data Published in “Frontiers in Medicine” Journal
American Gene Technologies® (AGT) designed AGT103-T in hopes of functionally curing HIV. The therapeutic is made of the patient's own T cells ...
Gene Therapy Clinical Trial Requirements
Gene Therapy Does It "My Way" In 1990, gene therapy burst onto the world stage with the first clinical trial aimed at ...
ShareTreck Host Interviews Jeff Galvin on The Future of Medicine
Raj Natarajan, host of ShareTreck, goes behind the scenes with Jeff Galvin, Founder and CEO of American Gene™ in this compelling interview ...
The Future of Gene Therapy
Economies of scale can apply to gene therapy too Gene therapy's advantage is its ability to modify the genetic cause of disease. ...
Monkeypox: Separating Fact from Fiction
With almost three years of COVID consuming our lives, a reprieve from viral outbreaks seemed deserved. However, that was not to be. ...
The FDA’s Evolving Approach to Drug Approval
Contributing Author John Vandermosten, Senior Biotechnology Analyst One hundred and fifty years ago, the world of medicine was radically different from today. The ...
2021 IPO & M&A Trends
Contributing Author John Vandermosten, Senior Biotechnology Analyst Transaction Trends 2021: Pandora's Box 2020 was a tremendous year for Initial Public Offerings (IPOs) where ...
Top Cell Therapy Approvals and Pipeline / Cell Therapy is More Than CAR T
Contributing Author John Vandermosten, Senior Biotechnology Analyst Cell therapy is the transfer of therapeutic cells to a patient. It replaces damaged cells or ...
FDA Gene Therapy Approvals
Despite the impact of the pandemic and the seemingly solitary focus of the health care machine on addressing SARS-CoV-2, the gene therapy ...
Chapter IV: Solving The Riddle, A Consequential Approach
The arc of HIV history has been developing over the last four decades. In the early days there was much we did ...
What Is CAR T-Cell Therapy? How It Works In 2-Minutes
Big Picture Cancer is a leading cause of death worldwide. In the U.S., only heart disease ranks above it. The American ...
What Is Stem Cell Therapy? How It Works In 2-Minutes
Big Picture Genomic medicine is bringing hope where none previously existed. This approach to cure and treat human diseases uses human ...
What Is Gene Editing? How It Works In 2-Minutes
Big Picture Gene therapy, stem cell therapy, CAR T, cell therapy, and gene editing are all forms of genomic medicine1 ...
Technology Transfer, A Catalyst For Gene Therapy Startups | The Spark Therapeutics Example
Contributing Author: Gina Hagler The ability to consistently bring treatments and cures to market depends upon a company's capacity to create ...
What Is Gene Therapy? How It Works In 2-Minutes
Contributing Author: Gina Hagler Big Picture Gene therapy, stem cell therapy, CAR-T, cell therapy and gene editing are all forms ...
Biotech IPOs 2020 and M&A Trends
Transaction Trends 2020 Life sciences transactions have boomed over the last year. Merger and acquisition (M&A) activity distinguished itself with ...
Rare Disease Moms Make Their Voices Heard | Three Inspirational Stories
Contributing Author: Gina Hagler There are 7,000 known rare diseases in the world. Each of them affects less than 1% of the ...
5 Ways Gene Therapy Companies are Transforming Rare Disease Cures
Contributing Author: Gina Hagler Historically, developing rare disease cures and treatments has been challenging. The small, globally dispersed patient population made it ...
A SPACtacular Way to Go Public
What Is A SPAC Anyway? 2020 turned out to be a fantastic year for private companies to go public. In a ...
3 Gene Therapy Companies Powering a Revolution in Rare Disease Cures
Contributing Author: Gina Hagler Gene therapy companies are powering a revolution in rare disease cures by offering treatments that target the genetic ...
5 Reasons Gene Therapy Companies are Vital to the Future of Biopharma
Contributing Author: Gina Hagler Pharmaceutical companies have been developing therapies to treat or prevent disease since the end of the 19th century. ...
5 Biotech Companies in Maryland That May Make History in 2021
Contributing Author: Gina Hagler These five biotechnology companies in Maryland may make history in 2021 because they have multiple therapeutic programs in ...
What Star Wars Can Teach Us About Cell Therapy Investments
Contributing Author: Gina Hagler It's difficult to believe there is anything that Star Wars can teach us about cell therapy, let alone ...
The Berlin Patient’s Success Produces A Flurry of Activity
The Berlin Patient's Success Produces A Flurry of Activity With an important milestone in the rearview mirror and clarity on the course ...
7 Cell Therapy Companies in Maryland Helping to Revolutionize Drug Discovery: The Latest News
Contributing Author: Gina Hagler Maryland is home to one of the largest life science clusters in the United States with more than 500 ...
The Race for a COVID Vaccine Foreshadows a Medical Revolution
Conventional vaccine development can take many years, yet vaccines targeting the novel coronavirus were approved and began distribution in under 12 months. ...
Rare Diseases: Why Are They Difficult to Cure?
Contributing Author: Gina Hagler Approximately 7,000 rare diseases affect 350-500 million people worldwide. The majority of these (80%) are monogenic, so-called because these ...
The History of HIV Cure Research: Reaching for a Cure
Contributing Author: Gina Hagler A new immune deficiency illness came on the scene in 1981. In the years immediately following, four questions arose ...
The History of HIV Cure Research: The Latest Research in BioPharma
Contributing Author: Gina Hagler In the forty years since the HIV/AIDS pandemic began in 1981, researchers have learned a lot about this disease ...
9 Reasons Treatment of Rare Diseases Will be Big in 2025
Of the 7,000 known rare diseases affecting 350 to 400 million people worldwide, most have a genetic basis and it often comes ...
Why Is It So Difficult to Find an HIV Cure?
More than 32 million people have died from AIDS-related illnesses since the start of the epidemic in 1981, making HIV/AIDS one of ...
ARC of HIV History 2 – A Beginning and an End
Contributing Author John Vandermosten, Senior Biotechnology Analyst This is the second installment of our series on the Arc of HIV History which examines ...
List of 88 Gene Therapies
Biotechnology is a rapidly expanding sector where game-changing innovation is a daily occurrence. Gene and cell therapies are of particular interest because ...
In Memory of Timothy Ray Brown
A Message From the CEO of American Gene Technologies® Timothy Ray Brown - March 11, 1966 - September 29, 2020 Timothy Ray ...
4 Global Trends That Will Affect HIV Cure Research in 2025
Contributing Author: Gina Hagler Researchers have been working on an HIV Cure since the first reports of the illness appeared in 1981. ...
The Arc of HIV History
The Early Days When We Knew Nothing It is uncertain how the human immunodeficiency virus or HIV initially infected humans although there ...
The History of HIV Cure Research: Discovery to Treatment
Contributing Author: Gina Hagler When reports of a new immune deficiency disease hit the news in the summer and fall of 1981, ...
Gene Therapy: More than Monogenic Disease
Contributing Author John Vandermosten, Senior Biotechnology Analyst Gene therapy is a diverse technology that can address a broad variety of diseases, conditions and ...
Treatment of Rare Diseases: What You Need to Know
Contributing writer: Gina Hagler What is a Rare Disease? The definition of a rare disease varies by country, with the consensus that ...
Rare Disease: One Mom’s Fight to Save Her Son, Amber Freed Raises Millions to Create a Cure. Coronavirus won’t stop her.
There are nearly 7,000 rare diseases affecting approximately 1% of the global population. When your child is affected with one of these ...
Top 5 Harvard Business Review Must Reads That Will Shape the Future of Biotechnology
The Harvard Business Review (HBR) has provided thought-provoking content since 1922. Whether business leaders are interested in optimizing their organizational structure or ...
Top 5 TED Talks on Gene Technology that Every Biotech Leader Must Watch
TED Talks began in 1984 as a conference originating in Silicon Valley where powerful voices in Technology, Entertainment, and Design came together ...
The Death of the Regulatory Barrier to Better Medicine
Written by Jeff Galvin, CEO of American Gene Technologies® The birth of high-value therapeutics and cures Does the development of effective drugs have ...
What Impact Did the Stock Market Crash Have on Biotech Stocks?
Contributing Author John Vandermosten, Senior Biotechnology Analyst Examining events of the past can give us a sense of what to expect in the ...
Benefits of FDA Orphan Drug Designation: What You Need to Know
by Irene Tennant VP of Clinical Product Development and Regulatory Affairs Developing treatments for rare diseases has many challenges. These challenges are ...
12 Coronavirus Stocks To Watch As The Race For A Coronavirus Vaccine and Treatment Continues
Contributing Author John Vandermosten, Senior Biotechnology Analyst Over the last two months nothing has dominated the news as extensively as the coronavirus pandemic ...
Gene Therapy M&A: Best Prospects 2020
Contributing Author John Vandermosten, Senior Biotechnology Analyst As we enter the twelfth year of an economic expansion, deal activity remains one of ...
WHAT IS GENE THERAPY?
Contributing Author: Norman Rogers, Former Business Development Lead at AGT ™ Gene therapy is a tool to modify the composition and expression ...
Cell Therapy is Creating the Next Generation Cures for Cancers
Today Human immunity is a beautifully complex system. Students of science around the world groan at the mention of immunology because of ...
Can HIV Be Cured? History of HIV Treatment Moving Toward an HIV Cure
You don’t have to look far to find someone affected by HIV. It is estimated 1.1 million Americans are infected with the ...
Is HIV Curable?
Is HIV Curable? American Gene Technologies® (AGT™) believes it is. Read why AGT's Chief Science Officer is committed to discovering a cure ...
Gene Therapy Companies in Maryland
Maryland is home to one of the largest life science clusters in the nation. According to the Maryland Department of Commerce, the ...
Gene Therapy Stocks 2019
Why has gene therapy become so significant within the last five years? While it is not well-known, the genes we are born ...
Business Innovation: 5 Disruptive Technology Leaders Tell You How To Develop Creativity and Innovation In The Workplace
American Gene Technologies® (AGT™) recently hosted a panel of thought leaders from five different industries at the Hot Technologies & Innovations event ...
Science Moms
At times mothers do not get enough credit. However, today, let's shine a light on the scientists who were raising children, at ...
Honoring Nurses On National Nurses Day
Today and this week are the times of year we honor nurses. On this National Nurses Day, we asked Caroline, a local ...
Scientific Discoveries That Changed Lives
There have been historic moments in scientific research that have gone unnoticed. Often we don’t hear about these scientific discoveries until they ...
Acquisition of Celgene – Medicine is Changing
On January 3rd, Bristol-Myers Squibb announced its agreement to acquire Celgene for approximately $74 billion. This merger is a sign of change ...
HIV Cure in the News
Today the world celebrated the second patient cured of HIV. The work of Ravindra Gupta teaches us lessons not only of the ...
Why Invest in an HIV Gene Therapy Cure?
Research and innovation to cure HIV is developing fast. American Gene Technologies® (AGT™) is emerging as a leader in the field with their ...
The Next Generation of Gene Therapy Companies
The future of medicine is bright. This year brought several first in class technologies over the finish line. The underpinning of these ...
The Gene Therapy Market is going to produce a Microsoft
The most common analogy used to compare the science of DNA to other industries is that of computer software. DNA can be ...
AGT™ Announces First-Ever Reddit AMA on the Potential of Gene Therapies
We are proud to have participated in our first-ever Reddit AMA on April 21, 2016. AGT CEO, Jeff Galvin and Chief Science ...
CEO Jeff Galvin Addresses Congress on the Biotechnology Investment Tax Credit
Jeff Galvin, CEO of American Gene Technologies® provided testimony in a Senate Hearing on March 8, 2016 in support of Maryland's Biotechnology ...
